Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy

doi:10.1016/j.jcmg.2023.10.010

Heart failure & cardiomyopathiesResearch article

Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy

JACC Cardiovasc ImagingPublished 13 Dec 2023

Narrative review

Read the original article ↗

Study context

Population: Patients with transthyretin amyloid cardiomyopathy (ATTR cardiomyopathy (ATTR-CM))

Main finding

As reported in the abstract

Role of multimodality cardiac imaging (echocardiography, scintigraphy, CMR) in ATTR-CM

Multimodality cardiac imaging allows accurate diagnosis of ATTR-CM
May help understand pathogenesis, predict prognosis and monitor treatment response

Original publication

Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy. JACC Cardiovasc Imaging. Published 13 December 2023. doi:10.1016/j.jcmg.2023.10.010

Read the original article ↗PubMedCite RIS · BibTeX

Summarised from the published abstract; every number is checked against it